# Recipharm Monts - Inspection Records

Source: https://www.globalkeysolutions.net/companies/recipharm-monts/e3b2f0c3-26eb-4020-8127-76127e9e18d6

> Inspection records and compliance data for Recipharm Monts in Monts, None. Access full analysis and detailed observations.

---

## Details

- Name: Recipharm Monts
- FEI Number: 1000171152
- City: Monts
- State: None
- Country Name: France
- Address Line 1: Site de Monts Sud, 18 rue de Montbazon
- Zip Code: None
- Facility Type: Pharmaceutical Manufacturer

## Related Documents

- [483 - Recipharm Monts - 2022-10-18](https://www.globalkeysolutions.net/records/483/recipharm-monts/a83c3605-dbd3-4083-aab4-aa70216b587a) — source: FDA, date: October 18, 2022
- [FDA Inspection 1181620 - Recipharm Monts - 2022-10-18](https://www.globalkeysolutions.net/records/fda_inspections/recipharm-monts/1e8094d2-a501-42d5-a694-2a4acf3c64b3) — classification: Official Action Indicated (OAI), source: FDA, date: October 18, 2022
- [483 - Recipharm Monts - 2019-11-12](https://www.globalkeysolutions.net/records/483/recipharm-monts/8da3ebc9-c75d-42d0-9fd6-150cb677753c) — source: FDA, date: November 12, 2019
- [483 - Recipharm Monts - 2019-11-12](https://www.globalkeysolutions.net/records/483/recipharm-monts/066bfcb2-5e84-479d-a346-8955e69b23e3) — source: FDA, date: November 12, 2019
- [FDA Inspection 1116762 - Recipharm Monts - 2019-03-29](https://www.globalkeysolutions.net/records/fda_inspections/recipharm-monts/6d6f7f96-cd3d-4333-9ca1-8e5e161ed82d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 29, 2019
- [FDA Inspection 940945 - Recipharm Monts - 2015-06-09](https://www.globalkeysolutions.net/records/fda_inspections/recipharm-monts/b0930f8a-db4b-4f30-83a8-668fdf63cee8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 9, 2015
- [483 - Recipharm Monts - 2013-02-26](https://www.globalkeysolutions.net/records/483/recipharm-monts/01138d7a-dab5-495d-a5da-6e0f03eb5d1e) — source: FDA, date: February 26, 2013
- [FDA Inspection 821445 - Recipharm Monts - 2013-02-26](https://www.globalkeysolutions.net/records/fda_inspections/recipharm-monts/940dab1d-4621-41f2-a4a6-6d62b88e1d11) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 26, 2013

## Related Companies

- [Novartis Pharmaceuticals Corporation](https://www.globalkeysolutions.net/companies/novartis-pharmaceuticals-corporation/21559fd5-35ed-4cbd-b228-623dd76bcf47)
- [Ipca Laboratories Limited](https://www.globalkeysolutions.net/companies/ipca-laboratories-limited/4221e8f5-a261-45fc-b9fc-d935bc1f225b)
- [Kite Pharma, Inc.](https://www.globalkeysolutions.net/companies/kite-pharma-inc/5bf88060-db53-466b-9a1c-85be7984894f)
- [FMKLABS](https://www.globalkeysolutions.net/companies/fmklabs/b335f624-1732-48b8-9900-26989b236b51)
- [Steril-Gene Life Sciences Private Ltd](https://www.globalkeysolutions.net/companies/steril-gene-life-sciences-private-ltd/0885ef5e-2fd7-42c0-927d-7cf3c2410eec)
- [Modavar Pharmaceuticals](https://www.globalkeysolutions.net/companies/modavar-pharmaceuticals/9b63702d-7db4-4738-8b79-5f7fc9cd73d6)
- [Unexo Life Sciences Private Limited](https://www.globalkeysolutions.net/companies/unexo-life-sciences-private-limited/0a2a6fc8-1ef3-46dc-a2ca-f4eb344630e3)
- [Aarkish Pharmaceuticals NJ Inc](https://www.globalkeysolutions.net/companies/aarkish-pharmaceuticals-nj-inc/62c50ef6-4542-4051-b9f0-04ba004fb177)
- [Pharmaplast S.A.E.](https://www.globalkeysolutions.net/companies/pharmaplast-sae/69fdda1e-d63c-4bd4-b5ed-402c137267a5)
- [Havix Group Inc](https://www.globalkeysolutions.net/companies/havix-group-inc/f038f97b-b3a3-4e4d-87d3-1366860c7e6d)

## Related Officers

- [S. Lori. Brown](https://www.globalkeysolutions.net/people/s-lori-brown/4bc9d367-3842-404d-a787-b8ce01e20da4)
- [Christopher S. Keating](https://www.globalkeysolutions.net/people/christopher-s-keating/94fcfd32-feb5-4b6c-80da-16202f4be01d)